Biotransformation of ginsenoside Rb1 to prosapogenins, gypenoside XVII, ginsenoside Rd, ginsenoside F2, and compound K by leuconostoc mesenteroides DC102

Journal of Ginseng Research

Volumn 35, Issue 3, 2011, Pages 344-351

  Quan, Lin Hu ^a   Piao, Jin Ying ^a   Min, Jin Woo ^a   Kim, Ho Bin ^a   Kim, Sang Rae ^a   Yang, Dong Uk ^a   Yang, Deok Chun ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Biotransformation; Compound K; Ginsenoside Rd; Gypenoside XVII; Leuconostoc mesenteroides DC102

Indexed keywords

LEUCONOSTOC MESENTEROIDES;

EID: 80053369117     PISSN: 12268453     EISSN: None     Source Type: Journal    
DOI: 10.5142/jgr.2011.35.3.344     Document Type: Article

References (28)

1. Boo YJ, Park JM, Kim J, Suh SO. Prospective study for Korean red ginseng extract as an immune modulator following a curative surgery in patients with advanced colon cancer. J Ginseng Res 2007;31:54-59.
2. Wu JY, Gardner BH, Murphy CI, Seals JR, Kensil CR, Recchia J, Beltz GA, Newman GW, Newman MJ. Sapo-nin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine. J Immunol 1992;148:1519-1525.
3. Wang BX, Cui JC, Liu AJ, Wu SK. Studies on the anti-fa-tigue effect of the saponins of stems and leaves of Panax ginseng (SSLG). J Tradit Chin Med 1983;3:89-94.
4. Odani T, Tanizawa H, Takino Y. Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. III. The absorption, distribution and excretion of ginsenoside Rb1 in the rat. Chem Pharm Bull (Tokyo) 1983;31:1059-1066.
5. Akao T, Kanaoka M, Kobashi K. Appearance of compound K, a major metabolite of ginsenoside Rb1 by intestinal bacteria, in rat plasma after oral administration-measurement of compound K by enzyme immunoassay. Biol Pharm Bull 1998;21:245-249.
6. Karikura M, Miyase T, Tanizawa H, Takino Y, Taniyama T, Hayashi T. Studies on absorption, distribution, excretion and metabolism of ginseng saponins. V. The decomposition products of ginsenoside Rb2 in the large intestine of rats. Chem Pharm Bull (Tokyo) 1990;38:2859-2861.
7. Paek IB, Moon Y, Kim J, Ji HY, Kim SA, Sohn DH, Kim JB, Lee HS. Pharmacokinetics of a ginseng saponin metabolite compound K in rats. Biopharm Drug Dispos 2006;27:39-45.
8. Hasegawa H, Uchiyama M. Antimetastatic efficacy of orally administered ginsenoside Rb1 in dependence on intestinal bacterial hydrolyzing potential and signifcance of treatment with an active bacterial metabolite. Planta Med 1998;64:696-700.
9. Lee BH, Lee SJ, Hur JH, Lee S, Sung JH, Huh JD, Moon CK. In vitro antigenotoxic activity of novel ginseng sapo-nin metabolites formed by intestinal bacteria. Planta Med 1998;64:500-503.
10. Wakabayashi C, Murakami K, Hasegawa H, Murata J, Saiki I. An intestinal bacterial metabolite of ginseng protopanaxadiol saponins has the ability to induce apop-tosis in tumor cells. Biochem Biophys Res Commun 1998;246:725-730.
11. Bae EA, Choo MK, Park EK, Park SY, Shin HY, Kim DH. Metabolism of ginsenoside R(c) by human intestinal bacteria and its related antiallergic activity. Biol Pharm Bull 2002;25:743-747.
12. Oh SH, Lee BH. A ginseng saponin metabolite-induced apoptosis in HepG2 cells involves a mitochondria-mediated pathway and its downstream caspase-8 activation and Bid cleavage. Toxicol Appl Pharmacol 2004;194:221-229.
13. Kim WY, Kim JM, Han SB, Lee SK, Kim ND, Park MK, Kim CK, Park JH. Steaming of ginseng at high temperature enhances biological activity. J Nat Prod 2000;63:1702-1704.
14. Wang BX, Cui JC, Liu AJ, Wu SK. Studies on the anti-fatigue effect of the saponins of stems and leaves of Panax ginseng (SSLG). J Tradit Chin Med 1983;3:89-94.
15. Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symposium Ser 1999;41:95-98.
16. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 2007;24:1596-1599.
17. Shibata S, Tanaka O, Soma K, Ando T, Iida Y, Nakamura H. Studies on saponins and sapogenins of ginseng. The structure of panaxatriol. Tetrahedron Lett 1965;42:207-213.
18. Quan LH, Cheng LQ, Kim HB, Kim JH, Son NR, Kim SY, Jin HO, Yang DC. Bioconversion of ginsenoside Rd into compound K by Lactobacillus pentosus DC101 isolated from Kimchi. J Ginseng Res 2010;34:288-295.
19. Dong A, Ye M, Guo H, Zheng J, Guo D. Microbial transformation of ginsenoside Rb1 by Rhizopus stolonifer and Curvularia lunata. Biotechnol Lett 2003;25:339-344.
20. Kim SD, Seu JH. Enzymatic properties of the convertible enzyme of ginseng saponin produced from Rhizopus japonicus. Korean J Appl Microbiol Bioeng 1989;17:126-130.
21. Zhang D, Liu Y, Yu H, Jin F, Chen G. Purifcation of gin-senoside β-glucosidase hydrolase and ITS characteristics. Chin J Appl Environ Biol 2003;9:259-262.
22. Sano K, Amemura A, Harada T. Purifcation and properties of a beta-1,6-clucosidase from Flavobacterium. Bio-chim Biophys Acta 1975;377:410-420.
23. Yoshioka H, Hayashida S. Purifcation and properties of β-glucosidase from Humicola insolens YH-8. Agric. Biol Chem 1980;44:1729-1735.
24. Park S Y, Bae EA, Sung JH, Lee SK, Kim DH. Purifca-tion and characterization of ginsenoside Rb1-metabolizing beta-glucosidase from Fusobacterium K-60, a human intestinal anaerobic bacterium. Biosci Biotechnol Biochem 2001;65:1163-1169.
25. Shin JE, Park EK, Kim EJ, Hong YH, Lee KT, Kim DH. Cytotoxicity of compound K (IH-901) and ginsenoside Rh2, main biotransformants of ginseng saponins by bi-fidobacteria, against some tumor cells. J Ginseng Res 2003;27:129-134.
26. Chi H, Ji GE. Transformation of ginsenosides Rb1 and Re from Panax ginseng by food microorganisms. Biotechnol Lett 2005;27:765-771.
27. Cheng LQ, Kim MK, Lee JW, Lee YJ, Yang DC. Conversion of major ginsenoside Rb1 to ginsenoside F2 by Cau-lobacter leidyia. Biotechnol Lett 2006;28:1121-1127.
28. Cheng LQ, Na JR, Kim MK, Bang MH, Yang DC. Micro-bial conversion of ginsenoside Rb1 to minor ginsenoside F2 and gypenoside XVII by Intrasporangium sp. GS603 isolated from soil. J Microbiol Biotechnol 2007;17:1937-1943.